Gisborne's Mātai Institute may have invented medical imaging 'third wave'

MRI pioneer Graeme Bydder, with Mātai Institute's Samantha Holdsworth, Paul Condron (holding a Bydder-edited textbook) and Daniel Cornfeld. (Photo: Mātai Institute)

Greg Hurrell

Mon, 22 Apr 2024

Gisborne’s Mātai Institute is leading a third wave in medical imaging technology, according to MRI pioneer Graeme Bydder.It has developed a way of detecting brain abnormalities in patients experiencing problems that standard MRI (magnetic resonance imaging) scans cannot see. The new method can be used on existing hospital equipment and has widespread implications for how several conditions are diagnosed and treated.If talk of a third wave sounds extravagant, New Zealand-born Bydder is more than qualified to say it. He was right there...

Subscribe to BusinessDesk

Stay informed on business, government and financial developments across New Zealand.

Stay informed on business, government and financial developments across New Zealand.
Deeply researched, twice-edited and fact-checked news
Annual subscribers also receive a complimentary subscription to The Wall Street Journal
Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers

You can cancel anytime with two clicks, an email or a phone call.
Find out more.

We are serious about journalism.

Name {{ registerForm.errors.get('name') }}

Email address {{ registerForm.errors.get('email') }}

Phone Number {{ registerForm.errors.get('phone') }}

Job Title {{ registerForm.errors.get('title') }}

Password Minimum password length of 8 characters.
Require at least one upper and lowercase, numeric, and special character. {{ registerForm.errors.get('password') }}

Repeat password {{ registerForm.errors.get('password_confirmation') }}

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Credit Card

Cardholder's name

{{ __(plans[index].interval) | capitalize }} {{ plans[index].attributes.old_price | currency }} {{ plans[index].price | currency }}

All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service

{{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}

Health

Compass calls Pita Pit, pie shop to the rescue

Nutritionists are not impressed.

Cécile Meier 6:20pm

Markets Market Close

NZ sharemarket flat despite Skellerup's record HY earnings

The S&P/NZX 50 Index closed at 12,905.98, down 7.97 points or 0.062%.

Graham Skellern 6:10pm

NZ sharemarket flat despite Skellerup's record HY earnings

Primary Sector

Workers brace for Kinleith decision

On Friday, Oji will update staff on a proposal to end paper production at the mill.

Oliver Lewis 3:50pm

Sponsored

Investing in US technology: Navigating a high-speed sector

A new exchange-traded fund gives Kiwis access to US tech giants.

Smart Invest

Sponsored

Security of supply: Marsden Point isn’t the issue as assurance offered for liquid fuel supply

How NZ will stay fuelled despite major global supply risks.

Z Energy

More Health

Health

Compass calls Pita Pit, pie shop to the rescue

Nutritionists are not impressed.

Cécile Meier 6:20pm

Law & Regulation

Class action targets ‘ineffective’ cold medicines

A class action has been filed claiming a pharmaceutical giant sold and marketed in New Zealand cold medicines that did not work.Australia-based JGA Saddler filed a class action against Johnson & Johnson NZ on Thursday over its phenylephrine-based cold medicines tablets and syrups...

Staff reporters 12:00pm